News Briefs: Data Critical/Elixis merger extends wireless capabilities

Article

Data Critical/Elixis merger extends wireless capabilitiesPursuing its goal of creating a wireless, Web-based clinical information system, Data Critical has agreed to buy Elixis, a privately held company that offers Web-based applications to access

Data Critical/Elixis merger extends wireless capabilities

Pursuing its goal of creating a wireless, Web-based clinical information system, Data Critical has agreed to buy Elixis, a privately held company that offers Web-based applications to access patient information and to automate repetitive tasks like coding and letter and prescription writing. Terms of the deal have yet to be disclosed.

This latest purchase closely follows Data Critical’s acquisition of Physix, a provider of mobile handheld workflow applications, for approximately $4.9 million in December 1999. Elixis will become part of a Data Critical subsidiary and will continue its existing distribution partnerships with Baxter Healthcare and Boston Scientific and its strategic alliances with drugstore.com, CVS.com, Physicians Online, MD Consult, and Healthstream.

© 2000 Miller Freeman, Inc., a United News & Media company.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.